ArticleMolecular psychiatry2026
Closed-loop transcranial alternating current stimulation (tACS) reduces cue reactivity and improves inhibitory control in methamphetamine use disorder with frequency and timing specificity.
Article in Molecular psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Methamphetamine use disorder (MUD) involves persistent cue reactivity and impaired inhibitory control, posing major treatment challenges. Closed-loop noninvasive neuromodulation can tailor stimulation to dynamic brain states, but its application in MUD remains largely unexplored. This study developed a cue reactivity biomarker-guided closed-loop transcranial alternating current stimulation (tACS) system, examined its optimal stimulation frequency, and preliminarily evaluated its efficacy in improving inhibitory control and reducing cue reactivity. Three cohorts of individuals with severe MUD were enrolled. Drug-cue exposure increased parietal-occipital theta power in Cohort 1. Based on this biomarker, a closed-loop tACS system targeting the left dorsolateral prefrontal cortex was developed. In Cohort 2, a within-subject crossover design examined closed-loop tACS at 6, 10, and 40 Hz. Random-time and open-loop continuous stimulation at the identified optimal frequency served as controls. In Cohort 3, an open-label, single-arm study of five consecutive daily closed-loop stimulation sessions assessed preliminary clinical efficacy. The results showed that closed-loop tACS at 40 Hz was the only condition that simultaneously reduced cue-related electroencephalographic (EEG) activity (P = 0.007) and improved inhibitory control (P = 0.031). Random-time stimulation reduced cue-related activity but did not improve inhibitory control, whereas open-loop continuous stimulation showed no significant effects. Repeated 40 Hz closed-loop tACS over five days in severe MUD significantly reduced craving and improved inhibitory control. These findings suggest that biomarker-guided 40 Hz closed-loop tACS can modulate neural and behavioral dysfunction in MUD and support the feasibility, safety, and preliminary efficacy of this neuromodulation strategy.
Identifiers
42680854What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.